Why is Brawn Biotech falling/rising?

As of 19-Aug, Brawn Biotech Ltd is currently priced at 18.00, with no change in price, reflecting a 0.00% movement. The stock has underperformed its sector by 0.81% today, despite showing a rising investor participation with a delivery volume increase of 47.93% against the 5-day average. In terms of returns, the stock has experienced a 1-week gain of 8.04%, although it has declined by 3.23% over the past month and is down 15.53% year-to-date. The stock is trading higher than its 5-day, 50-day, and 100-day moving averages, but lower than its 20-day and 200-day moving averages. There is no information available regarding positive or negative factors impacting the stock. Broader Market Context: The stock's recent performance contrasts with the benchmark Sensex, which has increased by 1.76% over the past week and is up 4.49% year-to-date. While Brawn Biotech has shown a strong short-term return relative to the benchmark, its longer-term performance remains concerning, with a year-to-date decline of 15.53% compared to the Sensex's positive return. This disparity highlights the challenges Brawn Biotech faces in maintaining investor confidence amidst broader market gains.